Clinical Trial Update: Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy of docosahexaenoic acid for tardive dyskinesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tardive Dyskinesia

Drugs mentioned

• Docosahexaenoic acid (docosahexaenoic acid)

Snippet

Sponsor: Université de Montréal | Conditions: Tardive Dyskinesia | Phase 2 | Status: UNKNOWN